Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Respiration Disorders

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Respiration Disorders in 1 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Respiration Disorders: Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Faingold, CL1
Randall, M1
Kommajosyula, SP1

Other Studies

1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Respiration Disorders

ArticleYear
Susceptibility to seizure-induced sudden death in DBA/2 mice is altered by adenosine.
    Epilepsy research, 2016, Volume: 124

    Topics: Adenosine; Animals; Caffeine; Death, Sudden; Disease Models, Animal; Disease Susceptibility; Dose-Re

2016